Agfa-Gevaert NV (EBR: AGFB)
Market Cap | 165.66M |
Revenue (ttm) | 1.13B |
Net Income (ttm) | -37.00M |
Shares Out | 154.82M |
EPS (ttm) | -0.24 |
PE Ratio | n/a |
Forward PE | 214.00 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 124,788 |
Open | 1.100 |
Previous Close | 1.098 |
Day's Range | 1.062 - 1.100 |
52-Week Range | 0.983 - 2.135 |
Beta | 0.69 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Sep 27, 2024 |
About Agfa-Gevaert NV
Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems worldwide. It operates through four segments: HealthCare IT, Digital Print & Chemicals, Radiology Solutions, and CONOPS. The company’s CONOPS segment engages in supply of film and chemicals, as well support services. Its Radiology Solutions segment offers analog and digital imaging technology for diagnostic imaging market to meet the needs of specialized clinicians in hospitals and imaging centers; and X-ray film, hardcopy film and printers, digital r... [Read more]
Financial Performance
Financial StatementsNews
![](https://cdn.snapi.dev/images/v1/c/w/press12-2612408.jpg)
The Agfa-Gevaert Group in Q2 2024: solid quarter, powered by growth engines - regulated information - inside information
Regulated information – Inside information August 28, 2024 - 7:45 a.m. CET The Agfa-Gevaert Group in Q2 2024: solid quarter, powered by growth engines
![](https://cdn.snapi.dev/images/v1/z/1/press18-2428621.jpg)
The Agfa-Gevaert Group in Q1 2024: weak start of the year, full year outlook maintained - regulated information
Regulated information – May 14, 2024 - 7:45 a.m. CET The Agfa-Gevaert Group in Q1 2024: weak start of the year, full year outlook maintained HealthCare IT: Soft quarter following a strong Q4 ...
![](https://cdn.snapi.dev/images/v1/3/7/press17-2321603.jpg)
Correction: The Agfa-Gevaert Group in 2023: Group EBITDA increases by 52%, powered by its growth engines - regulated information
CORRECTION ONLY IN DUTCH VERSION Regulated information – March 13, 2024 - 7:45 a.m. CET The Agfa-Gevaert Group in 2023: Group EBITDA increases by 52%, po...
![](https://cdn.snapi.dev/images/v1/n/j/press1-2321451.jpg)
The Agfa-Gevaert Group in 2023: Group EBITDA increases by 52%, powered by its growth engines - regulated information
Regulated information – March 13, 2024 - 7:45 a.m. CET The Agfa-Gevaert Group in 2023: Group EBITDA increases by 52%, powered by its growth engines HealthCare IT: Strong improvement in profit...
![](https://cdn.snapi.dev/images/v1/h/n/press1-2158606.jpg)
The Agfa-Gevaert Group in Q3 2023: overall EBITDA growth driven by strong performance of the growth engines, while film business under pressure
Regulated information – November 15, 2023 - 7:45 a.m. CET The Agfa-Gevaert Group in Q3 2023: overall EBITDA growth driven by strong performance of the growth engines, while film business unde...
![](https://cdn.snapi.dev/images/v1/c/x/press1-2146094.jpg)
Agfa-Gevaert: Publication of a transparency notification – Regulated information
Publication of a transparency notification – Regulated information (Article 14 of the law of May 2, 2007 on the disclosure of significant shareholdings) Mortsel, Belgium – November 8, 2023 – 7.45 a.m....
![](https://cdn.snapi.dev/images/v1/l/3/press17-2033497.jpg)
The Agfa-Gevaert Group in Q2 2023: continued progress for the growth engines
Regulated information – August 23 , 20 2 3 - 7:45 a.m. CET The Agfa-Gevaert Group in Q 2 202 3 : continued progress for the growth engines HealthCare IT: Increase in order intake of 1...
![](https://cdn.snapi.dev/images/v1/b/6/press11-1878511.jpg)
The Agfa-Gevaert Group in Q1 2023 - regulated information
Regulated information – May 9 , 20 2 3 - 7:45 a.m. CET The Agfa-Gevaert Group in Q1 202 3 : HealthCare IT: Increase in order intake of 25%, 4.8% revenue increase Profitability impacte...
![](https://cdn.snapi.dev/images/v1/p/r/press8-1626858.jpg)
Agfa-Gevaert Group Q3 Results 2022 - Regulated information – November 9, 2022 - 7:45 a.m. CET
Adjusted EBITDA increase of 8% with contrasted performances between the divisions HealthCare IT: organic sales growth, strong increase in order intake, solid profitability Digital Print & Chemicals: c...
![](https://cdn.snapi.dev/images/v1/p/r/press9-1528395.jpg)
Agfa-gevaert : Publication of a transparency notification – Regulated information
(Article 14 of the law of May 2, 2007 on the disclosure of significant shareholdings)
![](https://cdn.snapi.dev/images/v1/p/r/press4-1523721.jpg)
Agfa-Gevaert Group and AURELIUS Group sign share purchase agreement for sale of Agfa's Offset Solutions division - Regulated information
Mortsel, Belgium – August 30, 2022 – 8.15 a.m. CET
![](https://cdn.snapi.dev/images/v1/p/r/press16-1516780.jpg)
Agfa-Gevaert Half Year 2022 Results - Regulated information
Top line growth driven by Digital Print & Chemicals and Offset Solutions. Order book HealthCare IT at very healthy level – strong growth in order intake
![](https://cdn.snapi.dev/images/v1/p/r/press10-1440230.jpg)
Agfa-Gevaert: Cancellation of treasury shares – regulated information
Mortsel, Belgium – July 5, 2022 – 5:40 p.m. CET
![](https://cdn.snapi.dev/images/v1/p/r/press16-1414007.jpg)
Agfa-Gevaert : Share buyback program 2021 completed – regulated information
Mortsel, Belgium – June 13, 2022 – 5:40 p.m. CET
![](https://cdn.snapi.dev/images/v1/p/r/press7-1412020.jpg)
Agfa-Gevaert : Publication of a transparency notification – Regulated information
(Article 14 of the law of May 2, 2007 on the disclosure of significant shareholdings)
![](https://cdn.snapi.dev/images/v1/p/r/press3-1406487.jpg)
Agfa-Gevaert: Share buyback program – regulated information
Within the framework of the share buyback program which was announced in the press release of March 10, 2021, Agfa-Gevaert NV proceeded with the purchase of own shares on the market of Euronext Brusse...
![](https://cdn.snapi.dev/images/v1/p/r/press14-1365333.jpg)
Annual General Meeting of Agfa-Gevaert NV
Mortsel / Belgium, May 10, 2021 - 2.00 p.m. CET
![](https://cdn.snapi.dev/images/v1/p/r/press7-1364748.jpg)
Agfa-Gevaert: Q1 results - Regulated Informaton - The Agfa-Gevaert Group's EBITDA increases by 22% year-on-year in an extraordinary inflationary context
The Agfa-Gevaert Group's EBITDA increases by 22% year-on-year in an extraordinary inflationary context
![](https://cdn.snapi.dev/images/v1/p/r/press8-1363188.jpg)
Agfa-Gevaert: Share buyback program – Regulated information
Mortsel, Belgium – May 9, 2022 – 5:40 p.m. CET
![](https://cdn.snapi.dev/images/v1/p/r/press3-1354130.jpg)
Agfa-Gevaert: Publication of a transparency notification (Pendal) – Regulated information
(Article 14 of the law of May 2, 2007 on the disclosure of significant shareholdings)
![](https://cdn.snapi.dev/images/v1/p/r/press7-1295889.jpg)
Agfa-Gevaert NV: Share buyback program – regulated information
Within the framework of the share buyback program which was announced in the press release of March 10, 2021, Agfa-Gevaert NV proceeded with the purchase of own shares on the market of Euronext Brusse...
![](https://cdn.snapi.dev/images/v1/p/r/press13-1278840.jpg)
Agfa-Gevaert Group extends its Share Buyback Program 2021 – regulated information
Mortsel, Belgium – March 15, 2022 – 5:40 a.m. CET